FDA plans to expand remote evaluations, record reviews post-

The U.S. Food and Drug Administration (FDA) recently issued draft guidance on how it will continue to conduct remote regulatory assessments (RRAs) after the COVID-19 public health...

Related Keywords

, Public Health Emergency , Foreign Supplier Verification Program , Interactive Evaluations , Drug Manufacturing , Bioresearch Monitoring Facilities During , Health Emergency , Current Good Manufacturing Practice , Federal Food , Cosmetic Act ,